|
2024
|
Invention
|
Compounds and methods for yap/tead modulation and indications therefor.
Disclosed are compounds ... |
|
|
Invention
|
Compounds and methods for yap/tead modulation and indications therefor. 2344, Cx, p. q, v, X. and... |
|
|
Invention
|
Compounds and methods for yap/tead modulation and indications therefor. 2344, p, q, v, X, and Z a... |
|
|
Invention
|
Compounds and methods for yap/tead modulation and indications therefor. Disclosed are compounds o... |
|
|
Invention
|
Compounds and methods for yap/tead modulation and indications therefor. 234211,22 are as describe... |
|
2023
|
Invention
|
Compounds and methods for cd73 modulation and indications therefor. Disclosed are compounds of Fo... |
|
2022
|
Invention
|
Compounds and methods for yap/tead modulation and indications therefor. uisciosea are compo... |
|
|
Invention
|
Heterocyclic compounds and uses thereof. Provided herein are heterocyclic compounds of Formula (I... |
|
2021
|
Invention
|
Combinational drug therapies. (a) Compound I:
wherein the amount of the combination ... |
|
|
Invention
|
Solid forms of a compound for modulating kinases.
Forms of 4-(6-(3,5-dimethylisoxazol-4-yl)-1-[(... |
|
2020
|
Invention
|
Compounds and methods for ep300 or cbp modulation and indications therefor. Disclosed are compoun... |
|
2018
|
Invention
|
Solid forms of a compound for modulating kinases. Forms of 4-(6-(3,5-dimethylisoxazol-4-yl)-1-[(1... |
|
2017
|
Invention
|
Heterocyclic compounds and uses thereof. Heterocyclic compounds of formula (I), methods for their... |
|
2014
|
Invention
|
Compounds and methods for kinase modulation, and indications therefor. Compounds and salts thereo... |
|
2006
|
Invention
|
Program creation apparatus, program creation method and program. A program creation apparatus cre... |
